Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso

Detalhes bibliográficos
Autor(a) principal: Costa, Roseli Divino
Data de Publicação: 2017
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFMT
Texto Completo: http://ri.ufmt.br/handle/1/4358
Resumo: Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism. The classic form is caused by the deficiency in the enzyme phenylalanine hydroxylase (PAH) which catalyzes the hydroxylation of phenylalanine to tyrosine. Phenylketonuria (PKU) is detected and treated in Brazil at the National Newborn Screening Reference Services present in all Brazilian states. We tested for the IVS10nt-11G>A, V388M, R261Q, R261X, R252W and R408W mutations of the PAH gene in a sample of 19 patients being treated for PKU at the Newborn Screening Reference Service for the State of Mato Grosso. This study is crosssectional and descriptive and the 19 PKU patients in the study were detected over a 12 year period of newborn screening (2003 – 2015). Polymerase chain reaction (PCR) and specific restriction enzymes digestion were the techniques applied for the molecular analysis. Among the 19 patients that participated in this study 4 (21.1%) had two alleles identified; 5 (26.21%) patients had only one allele identified, and 10 (52.6%) were not found to have anyone of these six mutations. It was possible to identify 13/38 alleles, corresponding to 34.21% of the PAH alleles in the sample. The most prevalent mutation was V388M (13.2% of the alleles) followed by R261Q (10.1%) and IVS10nt-G>A (7.9%). Mutations R261X, R252W and R408W were not found. The most frequent types of mutations were missense, in 8 patients (18.4%) and splice in 4 patients (10.52%). Applying the model proposed by Guldberg et al. (1998), a genotype/phenotype correlation was obtained for the 4 patients with two identified mutations, all of whom had classic phenylketonuria. The predicted phenotype was moderate/mild or moderate PKU for 3 of these 4 classical PKU patients and the prediction coincided with the diagnosis of classic PKU in only 1 patient. The incidence of PKU for the State of Mato Grosso for the period from 2003 to 2015 was estimated to be 1:33,342 live births. The average coverage of the Newborn Screening Reference Service program for the State of Mato Grosso for this same period was 75.2% of all newborns. The mutations identified in this study were also found in several Brazilian studies, however, at a lower frequency than previously published data.
id UFMT_c0e54f8259eb3c717072f1e10838c49d
oai_identifier_str oai:localhost:1/4358
network_acronym_str UFMT
network_name_str Repositório Institucional da UFMT
repository_id_str
spelling Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato GrossoFenilcetonúriaMutaçõesTriagem neonatalMato GrossoCNPQ::CIENCIAS DA SAUDEPhenylketonuriaMutationNeonatal screeningMato GrossoPhenylketonuria (PKU) is an autosomal recessive inborn error of metabolism. The classic form is caused by the deficiency in the enzyme phenylalanine hydroxylase (PAH) which catalyzes the hydroxylation of phenylalanine to tyrosine. Phenylketonuria (PKU) is detected and treated in Brazil at the National Newborn Screening Reference Services present in all Brazilian states. We tested for the IVS10nt-11G>A, V388M, R261Q, R261X, R252W and R408W mutations of the PAH gene in a sample of 19 patients being treated for PKU at the Newborn Screening Reference Service for the State of Mato Grosso. This study is crosssectional and descriptive and the 19 PKU patients in the study were detected over a 12 year period of newborn screening (2003 – 2015). Polymerase chain reaction (PCR) and specific restriction enzymes digestion were the techniques applied for the molecular analysis. Among the 19 patients that participated in this study 4 (21.1%) had two alleles identified; 5 (26.21%) patients had only one allele identified, and 10 (52.6%) were not found to have anyone of these six mutations. It was possible to identify 13/38 alleles, corresponding to 34.21% of the PAH alleles in the sample. The most prevalent mutation was V388M (13.2% of the alleles) followed by R261Q (10.1%) and IVS10nt-G>A (7.9%). Mutations R261X, R252W and R408W were not found. The most frequent types of mutations were missense, in 8 patients (18.4%) and splice in 4 patients (10.52%). Applying the model proposed by Guldberg et al. (1998), a genotype/phenotype correlation was obtained for the 4 patients with two identified mutations, all of whom had classic phenylketonuria. The predicted phenotype was moderate/mild or moderate PKU for 3 of these 4 classical PKU patients and the prediction coincided with the diagnosis of classic PKU in only 1 patient. The incidence of PKU for the State of Mato Grosso for the period from 2003 to 2015 was estimated to be 1:33,342 live births. The average coverage of the Newborn Screening Reference Service program for the State of Mato Grosso for this same period was 75.2% of all newborns. The mutations identified in this study were also found in several Brazilian studies, however, at a lower frequency than previously published data.Fenilcetonúria (PKU) é um erro inato do metabolismo, autossômico rescessivo. A forma clássica é causada pela deficiência na enzima fenilalanina hidroxilase (PAH) que catalisa a hidroxilação de fenilalanina em tirosina. A fenilcetonúria (PKU) é detectada e tratada no Brasil nos Serviços de Referência em Triagem Neonatal, presente em todos os estados brasileiros. Este estudo é transversal e descritivo e os 19 pacientes com PKU no estudo foram detectados durante um período de 12 anos de triagem neonatal (2003-2015). Testamos as variantes IVS10nt-11G>A, V388M, R261Q, R261X, R252W e R408W do gene PAH em uma amostra de 19 pacientes tratados para PKU no Serviço de Referência em Triagem Neonatal do Estado de Mato Grosso. A reação em cadeia da polimerase (PCR) e a digestão das enzimas de restrição específicas foram às técnicas aplicadas para a análise molecular. Entre os 19 pacientes que participaram deste estudo, 4 (21,1%) tiveram dois alelos identificados; 5 (26,21%) pacientes tinham apenas um alelo identificado, e 10 (52,6%) não encontramos nenhuma dessas seis mutações. Foi possível identificar alelos de 13/38, correspondendo a 34,21% dos alelos PAH na amostra. A variante mais prevalente foi V388M (13,2% dos alelos) seguida de R261Q (10,1%) e IVS10nt-G>A (7,9%). Mutações R261X, R252W e R408W não foram encontradas. Os tipos mais frequentes de mutações foram troca de sentido, em 8 pacientes (18,4%) e de emenda em 4 pacientes (10,52%). Aplicando o modelo proposto por Guldberg et al. (1998), foi obtida uma correlação genótipo/fenótipo para os 4 pacientes com duas mutações identificadas, todas com fenilcetonúria clássica. O fenótipo previsto foi de PKU moderada/moderada ou moderada para 3 desses 4 pacientes clássicos de PKU e a predição coincidiu com o diagnóstico de PKU clássica em apenas 1 paciente. A incidência de PKU para o Estado de Mato Grosso para o período de 2003 a 2015 foi estimada em 1: 33.342 NV. A cobertura média do programa do Serviço de Referência de Triagem Neonatal para o Estado de Mato Grosso para este mesmo período foi de 75,2% de todos os recém-nascidos. As mutações identificadas neste estudo também foram encontradas em vários estudos brasileiros, porém, em menor frequência do que os dados publicados anteriormente.Universidade Federal de Mato GrossoBrasilFaculdade de Medicina (FM)UFMT CUC - CuiabáPrograma de Pós-Graduação em Ciências da SaúdeGalera, Marcial Francishttp://lattes.cnpq.br/3408657282738863Galera, Marcial Francis404.138.021-91http://lattes.cnpq.br/3408657282738863Ferreira, Maria de Fátima de Carvalho729.816.017-68http://lattes.cnpq.br/1416048337560983404.138.021-91Perez, Ana Beatriz Alvarez047.866.698-57http://lattes.cnpq.br/4784102068388854Costa, Roseli Divino2023-06-26T17:01:18Z2017-11-152023-06-26T17:01:18Z2017-08-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisCOSTA, Roseli Divino. Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso. 2017. 65 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Mato Grosso, Faculdade de Medicina, Cuiabá, 2017.http://ri.ufmt.br/handle/1/4358porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMTinstname:Universidade Federal de Mato Grosso (UFMT)instacron:UFMT2023-07-01T07:03:05Zoai:localhost:1/4358Repositório InstitucionalPUBhttp://ri.ufmt.br/oai/requestjordanbiblio@gmail.comopendoar:2023-07-01T07:03:05Repositório Institucional da UFMT - Universidade Federal de Mato Grosso (UFMT)false
dc.title.none.fl_str_mv Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
title Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
spellingShingle Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
Costa, Roseli Divino
Fenilcetonúria
Mutações
Triagem neonatal
Mato Grosso
CNPQ::CIENCIAS DA SAUDE
Phenylketonuria
Mutation
Neonatal screening
Mato Grosso
title_short Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
title_full Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
title_fullStr Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
title_full_unstemmed Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
title_sort Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso
author Costa, Roseli Divino
author_facet Costa, Roseli Divino
author_role author
dc.contributor.none.fl_str_mv Galera, Marcial Francis
http://lattes.cnpq.br/3408657282738863
Galera, Marcial Francis
404.138.021-91
http://lattes.cnpq.br/3408657282738863
Ferreira, Maria de Fátima de Carvalho
729.816.017-68
http://lattes.cnpq.br/1416048337560983
404.138.021-91
Perez, Ana Beatriz Alvarez
047.866.698-57
http://lattes.cnpq.br/4784102068388854
dc.contributor.author.fl_str_mv Costa, Roseli Divino
dc.subject.por.fl_str_mv Fenilcetonúria
Mutações
Triagem neonatal
Mato Grosso
CNPQ::CIENCIAS DA SAUDE
Phenylketonuria
Mutation
Neonatal screening
Mato Grosso
topic Fenilcetonúria
Mutações
Triagem neonatal
Mato Grosso
CNPQ::CIENCIAS DA SAUDE
Phenylketonuria
Mutation
Neonatal screening
Mato Grosso
description Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism. The classic form is caused by the deficiency in the enzyme phenylalanine hydroxylase (PAH) which catalyzes the hydroxylation of phenylalanine to tyrosine. Phenylketonuria (PKU) is detected and treated in Brazil at the National Newborn Screening Reference Services present in all Brazilian states. We tested for the IVS10nt-11G>A, V388M, R261Q, R261X, R252W and R408W mutations of the PAH gene in a sample of 19 patients being treated for PKU at the Newborn Screening Reference Service for the State of Mato Grosso. This study is crosssectional and descriptive and the 19 PKU patients in the study were detected over a 12 year period of newborn screening (2003 – 2015). Polymerase chain reaction (PCR) and specific restriction enzymes digestion were the techniques applied for the molecular analysis. Among the 19 patients that participated in this study 4 (21.1%) had two alleles identified; 5 (26.21%) patients had only one allele identified, and 10 (52.6%) were not found to have anyone of these six mutations. It was possible to identify 13/38 alleles, corresponding to 34.21% of the PAH alleles in the sample. The most prevalent mutation was V388M (13.2% of the alleles) followed by R261Q (10.1%) and IVS10nt-G>A (7.9%). Mutations R261X, R252W and R408W were not found. The most frequent types of mutations were missense, in 8 patients (18.4%) and splice in 4 patients (10.52%). Applying the model proposed by Guldberg et al. (1998), a genotype/phenotype correlation was obtained for the 4 patients with two identified mutations, all of whom had classic phenylketonuria. The predicted phenotype was moderate/mild or moderate PKU for 3 of these 4 classical PKU patients and the prediction coincided with the diagnosis of classic PKU in only 1 patient. The incidence of PKU for the State of Mato Grosso for the period from 2003 to 2015 was estimated to be 1:33,342 live births. The average coverage of the Newborn Screening Reference Service program for the State of Mato Grosso for this same period was 75.2% of all newborns. The mutations identified in this study were also found in several Brazilian studies, however, at a lower frequency than previously published data.
publishDate 2017
dc.date.none.fl_str_mv 2017-11-15
2017-08-29
2023-06-26T17:01:18Z
2023-06-26T17:01:18Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv COSTA, Roseli Divino. Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso. 2017. 65 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Mato Grosso, Faculdade de Medicina, Cuiabá, 2017.
http://ri.ufmt.br/handle/1/4358
identifier_str_mv COSTA, Roseli Divino. Estudo das mutações IVS10NT-11G>A, V388M, R261Q, R261X, R252W E R408W no gene da fenilalanina hidroxilase em pacientes com fenilcetonúria do estado de Mato Grosso. 2017. 65 f. Dissertação (Mestrado em Ciências da Saúde) - Universidade Federal de Mato Grosso, Faculdade de Medicina, Cuiabá, 2017.
url http://ri.ufmt.br/handle/1/4358
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Mato Grosso
Brasil
Faculdade de Medicina (FM)
UFMT CUC - Cuiabá
Programa de Pós-Graduação em Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Mato Grosso
Brasil
Faculdade de Medicina (FM)
UFMT CUC - Cuiabá
Programa de Pós-Graduação em Ciências da Saúde
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMT
instname:Universidade Federal de Mato Grosso (UFMT)
instacron:UFMT
instname_str Universidade Federal de Mato Grosso (UFMT)
instacron_str UFMT
institution UFMT
reponame_str Repositório Institucional da UFMT
collection Repositório Institucional da UFMT
repository.name.fl_str_mv Repositório Institucional da UFMT - Universidade Federal de Mato Grosso (UFMT)
repository.mail.fl_str_mv jordanbiblio@gmail.com
_version_ 1804648518503104512